Ultragenyx Announces Workforce Reduction and Strategic Restructuring
at www.tipranks.com (Tue, 3-Nov 4:44 PM)
Ultragenyx Pharmaceutical GAAP EPS of -$1.16 misses by $0.14, revenue of $173M misses by $10.71M
at seekingalpha.com (Tue, 3-Nov 4:14 PM)
Ultragenyx’s GTX-102 Angelman Syndrome Study Terminated: What Investors Should Know
at www.tipranks.com (Tue, 3-Nov 11:30 AM)
Ultragenyx granted conditional U.K. nod for Dojolvi
at seekingalpha.com (Fri, 30-Oct 11:46 AM)
Ultragenyx wins first FDA approval for Sanfilippo Type A with single-dose gene therapy FAYUVI
Market Chameleon (Fri, 18-Sep 7:07 AM)
